Related Experiment Video

Updated: Jun 14, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

Molecular mechanism of cell apoptosis by paclitaxel and pirarubicin in a human osteosarcoma cell line

Si-Yuan Liu1, Shu-Xia Song, Liang Lin

  • 1Department of Orthopedic Oncology, Third Hospital, Hebei Medical University, Shijiazhuang, PR China. LiusiYuan2004 @ yahoo.com

Chemotherapy
|April 2, 2010
PubMed
Abstract

Insights

Paclitaxel and pirarubicin induce cell cycle arrest and apoptosis in osteosarcoma cells. These effects are dependent on the Bcl-2/Bax ratio, suggesting potential for combination therapy.

Area of Science:

  • Oncology
  • Cell Biology
  • Pharmacology

Background:

  • Paclitaxel and pirarubicin possess known cytotoxic and antitumor properties.
  • Limited data exists on their specific apoptosis-inducing mechanisms in human osteosarcoma MG-63 cells.

Purpose of the Study:

  • To investigate the effects of paclitaxel and pirarubicin on cell cycle progression and apoptosis in MG-63 cells.
  • To elucidate the molecular mechanisms, including protein expression changes, underlying these effects.

Main Methods:

  • MG-63 cells were treated with paclitaxel and pirarubicin.
  • Flow cytometry was employed to analyze cell cycle arrest and apoptosis.
  • Western blotting assessed the expression of PCNA, Bcl-2, Bax, cyclin D1, and cyclin E.

Main Results:

  • Paclitaxel induced G2/M arrest, while pirarubicin caused G0/G1 arrest.
  • Apoptosis induction by paclitaxel correlated with treatment duration.
  • Pirarubicin-induced apoptosis showed duration dependence at lower concentrations (10^2-10^3 nM).
  • Both drugs decreased PCNA, cyclin D1, cyclin E, and Bcl-2 expression, while increasing Bax expression.

Conclusions:

  • Paclitaxel and pirarubicin trigger G2/M or G0/G1 cell cycle arrest and apoptosis in osteosarcoma cells.
  • The observed effects are mediated through a Bcl-2/Bax dependent pathway.
  • These findings support the potential efficacy of combining paclitaxel and pirarubicin for osteosarcoma treatment.

More Related Videos

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells15:53

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...